2019 Research Articles

Overview

• The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO).  PMID: 30645678
• Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management.  PMID: 31584459
• Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.  PMID: 31552207
• Small Intestinal Bacterial Overgrowth.  PMID: 31536241
• Is A Real Condition?  PMID: 31550680  

 
Pathophysiology 

• Infection-Induced Intestinal Dysbiosis Is Mediated by Macrophage Activation and Nitrate Production.  PMID: 31138751
• Mo1615 – Fat-Soluble Vitamins, B12, and Iron Deficiency in Patients with Coliform Small Intestinal Bacterial Overgrowth.  DOI: 10.1016/S0016-5085(19)38959-0
• 4 – First Large Scale Study Defining the Characteristic Microbiome Signatures of Small Intestinal Bacterial Overgrowth (SIBO): Detailed Analysis from the Reimagine Study.  DOI: 10.1016/S0016-5085(19)36776-9
• Sa1755 – Presenting Symptom Severity and Health-Related Quality of Life Do Not Predict Lactulose Breath Test Outcomes in Patients with Suspected Small Intestinal Bacterial Overgrowth.  DOI: 10.1016/S0016-5085(19)37822-9
• Sa1911 – Analysis of the Small Intestinal Microbiome Reveals Marked Differences from Stool Microbiome in a Large Scale Human Cohort: Redefining the “Gut Microbiome”.  DOI: 10.1016/S0016-5085(19)37977-6   
• Carbohydrate Intolerance and Disaccharidase Measurement - a Mini-Review.  PMID: 31857738  ​

Causes/ Risk Factors
 
   Appendicitis  NEW

• 1149 – Microbial Sequencing of the Appendiceal Microbiome Reveals Elevated Levels of C. Jejuni in Acute Appendicitis  doi: 10.1016/S0016-5085(19)37416-5

   Biofilm

• 443 – Intestinal Biofilms are an Endoscopic Feature of Irritable Bowel Syndrome.  DOI: 10.1016/S0016-5085(19)37016-7

   Diseases

• Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging.  PMID: 31839961

    Food Poisoning

• Sa1954 – Post Infection IBS (PI-IBS) is Very Infrequent in Mexico and Patients Have Similar Characteristics Than Those with Non Pi-Ibs Ones.  DOI: 10.1016/S0016-5085(19)38020

   PPI's/Hypochlorhydria 

• Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.  PMID: 29678362
• 979 – A Large Scale Evaluation of the Small Intestinal Microbiome in Subjects on Proton Pump Inhibitors.  DOI: 10.1016/S0016-5085(19)37311-1

   Surgery

• Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass.  PMID: 31187458
• Small intestinal bacterial overgrowth is common after gastrectomy but with little impact on nutritional status.  DOI: 10.1016/j.gastre.2019.01.007
• Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.  PMID: 31626698
• Partially hydrolyzed guar gum alleviates small intestinal mucosal damage after massive small bowel resection along with changes in the intestinal microbiota.  PMID: 31515113

   Weight

• Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis.  PMID: 31605277 
• Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change.  PMID: 31861004

 

Associated Conditions
 
   Anorexia Nervosa  NEW

• Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation.  PMID: 31510101

   Anxiety/Depression

• 858 – Therapeutic Response to Small Intestinal Bacterial Overgrowth (SIBO) in Irritable Bowel Syndrome (IBS). is It Useful to Test For?.  DOI: 10.1016/S0016-5085(19)37267-1

   Brain Fog

• Mo1610 – Characterizing Symptoms of Brain Fogginess and Its Association with D-Lactic Acidosis and Sibo.  DOI: 10.1016/S0016-5085(19)38954-1

   Cancer  NEW

• Clinical evaluation and treatment of chronic bowel symptoms following cancer in the colon and pelvic organs.  PMID: 30698052
• Association between small intestinal bacterial overgrowth and toll-like receptor 4 in patients with pancreatic carcinoma and cholangiocarcinoma.  PMID: 30457560
• Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.  DOI:10.1016/j.hbpd.2018.11.002
• Relationship of TLR2 and TLR4 expressions on the surface of peripheral blood mononuclear cells to small intestinal bacteria overgrowth in patients with hepatocellular carcinoma.  PMID: 31082340

   Celiac Disease

• METABOLIC ALTERATIONS IN CELIAC DISEASE OCCURRING AFTER FOLLOWING A GLUTEN-FREE DIET.  DOI: 10.1159/000495749

   Children (Pediatrics)

• Impact of Small Intestine Bacterial Overgrowth on Response to a Nutritional Intervention in Bangladeshi Children from an Urban Community.  PMID: 30479249
• Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.  PMID: 31552207
• Increased Fecal Lactobacillus Is Associated With a Positive Glucose Hydrogen Breath Test in Bangladeshi Children.  PMID: 31281862
• Monitoring of long-term parenteral nutrition in children with intestinal failure.  PMID: 31061893
• Gastrointestinal Conditions in Children With Severe Feeding Difficulties.  PMID: 31020010
• Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center.  PMID: 30826119
• Risk Factors of Ambulatory Central Line-Associated Bloodstream Infection in Pediatric Short Bowel Syndrome.  PMID: 31179578
• Small intestinal bacterial overgrowth: could it be associated with chronic abdominal pain in children with allergic diseases?  PMID: 31617366
• Small intestinal bacterial overgrowth in children with intestinal failure on home parenteral nutrition.  PMID: 31633044

   Cholangitis  NEW

• A Mechanistic Insight Into the Role of Gut Microbiota in the Pathogenesis of Primary Sclerosing Cholangitis.  DOI:10.1053/j.gastro.2019.10.012

   Cystic Fibrosis

• Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption.  DOI: 10.1016/j.drudis.2018.11.009

   Diabetes

• Diabetes and the gastrointestinal tract. DOI: 10.1016/j.mpmed.2019.04.011

   Diverticular Disease

• Overview on the management of diverticular disease by Italian General Practitioners.  DOI: 10.1016/j.dld.2018.07.015
•  A Set Up for SIBO.  PMID: 30639676

   Environmental Enteric Dysfunction

• Environmental enteric dysfunction and growth.  PMID: 30629923

   Gallbladder Disease

• High occurrence of small intestinal bacterial overgrowth in primary biliary cholangitis.  PMID: 31373141

   GERD

• Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.  PMID31114137

   Heart Failure

• Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure.  DOI: 10.1016/j.cardfail.2018.10.004
• Impact of intestinal microbiota in patients with heart failure: A systematic review.  DOI: 10.1016/j.medcle.2019.06.017

   Inflammatory Bowel Disease

• Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.  PMID: 31496621

• Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease.  PMID: 30735254
• Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
• Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients.  PMID: 31626698

   Intestinal Failure: Pediatric

• Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study.  PMID: 30035316

   Irritable Bowel Syndrome

• Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.  PMID: 31688023 
• Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance.  PMID: 31765575 
• Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
• A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.  PMID: 31750966 
• Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.  PMID: 31674052 
• Irritable bowel syndrome and gut microbiota.  PMID: 31789724

   Liver Disease

• Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease.  PMID:30915401
• An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.  PMID: 30896956
• The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.  PMID: 30894137
• Alcoholic liver disease and mast cells: What's your gut got to do with it?   https://doi.org/10.1016/j.livres.2019.02.002
• Role of the intestinal microbiome in liver fibrosis development and new treatment strategies.  DOI: 10.1016/j.trsl.2019.02.005
• Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.  DOI:10.1016/j.hbpd.2018.11.002
• An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.  PMID: 30896956
• Su1083 – Small Intestinal Bacterial Overgrowth and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.  DOI: 10.1016/S0016-5085(19)40180-7
• Mo2015 – The Role of Small Intestinal Bacteria Overgrowth in Nonalcoholic Fatty Liver Disease.  DOI: 10.1016/S0016-5085(19)39278-9
• Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?  PMID: 31767551

   Metabolic Syndrome

• The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome.  DOI: 10.1016/j.redox.2018.101091

   Obesity (morbid)

• An assessment of bacterial overgrowth and translocation in the non-alcoholic fatty liver of patients with morbid obesity.  PMID: 30896956
• Mo2023 – Association Between Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Metaanalysis.  DOI: 10.1016/S0016-5085(19)39287-X
• Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis.  PMID: 31605277 
• Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change.  PMID: 31861004

   Pancreatic Disease

• Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression.  PMID: 31517648
• Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use.  PMID: 31008737
• Association between increased breath hydrogen methane concentration and prevalence of glucose intolerance in acute pancreatitis.  PMID: 31689699
• Altered diversity and composition of gut microbiota in Chinese patients with chronic pancreatitis. DOI: 10.1016/j.pan.2019.11.013

   Parkinson’s Disease

• Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption.  DOI: 10.1016/j.drudis.2018.11.009
• Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis.  DOI:10.1016/j.tins.2018.09.007
• Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.  PMID: 31681153
• Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease.  PMID: 31678900

   Polyderma faciale NEW

• Pyoderma faciale in a patient with small intestinal bacterial overgrowth.  PMID: 30968945

   Restless Legs Syndrome

• Restless Leg Syndrome: Does It Start With A Gut Feeling? https://doi.org/10.1093/sleep/zsz067.008

   Sexual Dysfunction  NEW

• Could problems in the bedroom come from our intestines? A preliminary study of IBS and its impact on female sexuality.  PMID: 31488791

   Short Bowel Syndrome

• Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center.  PMID: 30826119
• DPP4 inhibitor reinforces cell junction proteins in mouse model of short syndrome.  PMID: 31576468
• Risk Factors of Ambulatory Central Line-Associated Bloodstream Infection in Pediatric Short Bowel Syndrome.  PMID: 31179578

   Surgery: Gastric By-pass/Bariatric

• Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO.  PMID: 30627990
• Gut Microbiota Imbalance Can Be Associated with Non-malabsorptive Small Bowel Shortening Regardless of Blind Loop.  PMID: 30293133

   Systemic Sclerosis

• Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.  PMID: 30729669
• Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.  PMID: 31549334

Testing

• Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO.  PMID: 30627990
• Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study.  PMID: 30035316
• Noninvasive Magnetogastrography Detects Erythromycin-Induced Effects on the Gastric Slow Wave.  PMID: 29993499 (MMC testing)
• BREATH TESTS FOR SMALL INTESTINAL BACTERIAL OVERGROWTH DIAGNOSIS: A SYSTEMATIC REVIEW WITH META-ANALYSIS.  https://doi.org/10.1016/S1590-8658(19)30442-6
• Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels. PMID: 31152332
• Gastric, small bowel and colonic motility and breath-testing.  DOI: 10.1016/j.mpmed.2019.03.006
• First Large Scale Study Defining the Characteristic Microbiome Signatures of Small Intestinal Bacterial Overgrowth (SIBO): Detailed Analysis from the Reimagine Study.  DOI: 10.1016/S0016-5085(19)36776
• Su1949 – Small Intestinal Aspirates Require Specific Treatment to Optimize Microbial Analysis: Validation of a Novel Technique from the Reimagine Study  DOI: https://doi.org/10.1016/S0016-5085(19)38583-X
• Sa1912 – Revealing the Entire Intestinal Microbiota and Its Associations to the Genetic, Immunologic, and Neuroendocrine Ecosystems: Methodology for the Reimagine Study.  DOI: https://doi.org/10.1016/S0016-5085(19)37978-8
• P.06.12 BREATH TESTS FOR SMALL INTESTINAL BACTERIAL OVERGROWTH DIAGNOSIS: A SYSTEMATIC REVIEW WITH META-ANALYSIS.  DOI: 10.1016/S1590-8658(19)30442-6
• Tu1873 – Bowel Cleansing May Affect Diagnostic Yield of Small Bowel Aspirates for Diagnosis of Sibo in Patients with Diarrhea.  DOI: 10.1016/S0016-5085(19)39856-7
• Tu1600 – Air Or Carbon Dioxide Insufflation in Upper Endoscopies and the Yield of Quantitative Small Bowel Aspirate Cultures.  DOI: 10.1016/S0016-5085(19)39605-2
• Sa1953 – Pictograms are Highly Effective for Diagnosing Abdominal Bloating and Distension in Patients with Irritable Bowel Syndrome (IBS).  DOI: 10.1016/S0016-5085(19)38019-9
• Su1949 – Small Intestinal Aspirates Require Specific Treatment to Optimize Microbial Analysis: Validation of a Novel Technique from the Reimagine Study.  DOI: 10.1016/S0016-5085(19)38583-X
• Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome.  DOI: 10.1016/j.amjms.2018.11.004.
• Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.  PMID: 30862994
• Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity.  PMID: 31563879
• Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study.  PMID: 3146469
• Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders.  PMID: 31043597
• Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study.  PMID: 31675917
• Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.  PMID: 31688023
• Carbohydrate Intolerance and Disaccharidase Measurement - a Mini-Review.  PMID: 31857738
• Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.  PMID: 31617133
• Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993
• Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.  PMID: 31674052
• Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis.  PMID: 31743632

Methane

• Tu1887 – Patients with Appendectomy Have Significantly Less Methane in Their Exhaled Breath: is the Appendix a Vestigial Organ Or an Important Reservoir for Methanogens?  doi: 10.1016/S0016-5085(19)39870-1
• Tu1897 – Enteric Methane Or Hydrogen Production in Patients with Unexplained Gastrointestinal Symptoms: Associations with Age, Symptoms and Proton Pump Inhibitors  doi: 10.1016/S0016-5085(19)39880-4
• Su1635 – Oral Iron Supplementation, Microbiome Related Methanogenesis and Constipation - a Novel Model to Explain and Age Old Problem  doi: 10.1016/S0016-5085(19)38374-X
  
  

Hydrogen Sulfide

• SIBO AS AN ADAPTATION: A PROPOSED ROLE FOR HYDROGEN SULFIDE NDNR
• Sa1918 – Jejunal But Not Colonic Hydrogen Sulfide Increased Portal Blood Flow But Not Portal Pressure.  DOI: 10.1016/S0016-5085(19)37984-3
• Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis. PMID: 31754993

 
 
Treatment 

• Management of Small Intestinal Bacterial Overgrowth in Adult Patients.  PMID: 31145251

   Antibiotics

• Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.  PMID: 31549334
• Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans.  PMID: 31428718
• Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome.  DOI: 10.1016/j.amjms.2018.11.004.
• Su1589 – Predictive Factors of Response to Rifaximin in Irritable Bowel Syndrome and Bacterial Overgrowth.  DOI: 10.1016/S0016-5085(19)38328-3
• 444 – Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) Using Modified Definitions of Pain Response.  DOI: 10.1016/S0016-5085(19)37017-9
• Mo1545 – Characterization of Abdominal Pain Response to Rifaximin in Patients with Irritable Bowel Syndrome with Diarrhea (IBSD), by Baseline Pain Severity
• Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.  PMID: 31688023

   
  Bacteriophage  NEW

• Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.  PMID: 31750259

  Prokinetics

• Rikkunshito Depolarizes Pacemaker Potentials of Cultured Interstitial Cells of Cajal through Ghrelin Receptors in Murine Small Intestine.  PMID: 30889598
• Prucalopride for the treatment of constipation: a view from 2015 and beyond.  PMID:30791758
• Prucalopride, A Recently Approved Drug by the Food and Drug Administration for Chronic Idiopathic Constipation.  PMID: 30820411
• The effect of pyridostigmine on small intestinal bacterial overgrowth(SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies.  PMID: 31098925
• Mo1584 – Effectiveness of Lanreotide in the Treatment of Patients with Small Bowel Motility Disorder (SBMD).  DOI: 10.1016/S0016-5085(19)38928-0
• In brief: Tegaserod (Zelnorm) returns.  PMID: 31169806
• Prucalopride (Motegrity) for chronic idiopathic constipation.  PMID: 31170120
• Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation.  PMID: 31218146
• Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350.  PMID: 31134513
• Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study.  PMID: 31134512
• Use of prucalopride in adults with chronic idiopathic constipation.  PMID: 31096799

  Probiotics

• Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.  PMID: 31549334
• Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.  PMID: 29508268
• Sa1936 – Efficacy and Safety of Saccharomyces Boulardii Cncm I -745 in the Treatment of Small Intestinal Bacterial Overgrowth in Patients Suffering Irritable Bowel Syndrome with Diarrhea.  DOI: 10.1016/S0016-5085(19)38002-3
• Mo1543 – The Effect of Low Fodmap Diet Management in Combination with Bifidobacteria on IBS Patients in Western China:A Prospective Randomized Trail.  DOI: 10.1016/S0016-5085(19)38887-0
• Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.  PMID31114137

  
  Acupuncture

• Acupuncture protects the interstitial cells of Cajal by regulating miR-222 in a rat model of post-operative ileus.  PMID: 30852906

• Ameliorating Effects of Electroacupuncture on Dysmotility, Inflammation and Pain Mediated via the Autonomic Mechanism in a Rat Model of Postoperative Ileus.  PMID: 30827069

  Fecal Microbiota Transplantation (FMT)

• Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation.  PMID: 31510101
• Tu1878 – Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS): A Systematic Review and Meta-Analysis.  DOI: 10.1016/S0016-5085(19)39861-

  Diet

• Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.  PMID: 30626117
• The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence.  PMID: 31505870
• The role of diet in irritable bowel syndrome: implications for dietary advice.  PMID: 31468640
• Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.  PMID: 30862994 
• Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders.  PMID: 31043597
• The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence.  PMID: 31505870
• The role of diet in irritable bowel syndrome: implications for dietary advice.  PMID: 31468640
• Reaction of antibodies to Campylobacter jejuni and cytolethal distending toxin B with tissues and food antigens.  PMID: 30862994 

 
  FODMAP Diet

• Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course.  PMID: 30873577
• Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study.  PMID: 30834032
• Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome.  PMID: 30827068
• REPLY TO THE LETTER: Prebiotics Versus Low Fodmap Diet: An Interpretative Nightmare.  PMID: 30794765
• Exit Gluten-Free and Enter Low FODMAPs: A Novel Dietary Strategy to Reduce Gastrointestinal Symptoms in Athletes.  PMID: 30671907
• Effect of a short-term low fermentable oligiosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet on exercise-related gastrointestinal symptoms.  PMID: 30646926
• Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study.  PMID: 30644587
• Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research.  PMID: 30589971
• Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?  PMID: 30543574
• The Effect of Diet on Irritable Bowel Syndrome Symptoms and Its Role in the Treatment Plan (P12-001-19).  PMID: 31224179
• How Patients with IBS Use Low FODMAP Dietary Information Provided by General Practitioners and Gastroenterologists: A Qualitative Study.  PMID: 31205130
• Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome.  PMID: 31205130
• EVALUATION OF CARBOHYDRATE AND FIBER CONSUMPTION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN OUTPATIENT TREATMENT.  PMID: 31141064
• The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea.  PMID: 31103370
• Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review.  PMID: 31080496
• Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia.  PMID: 31061894
• Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.  PMID: 31029650
• Elimination of Fermentable Carbohydrates to Reduce Gastrointestinal Symptoms in Pediatric Patients With Irritable Bowel Syndrome: A Narrative Review.  PMID: 30937981
• Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?  PMID: 30935559
• Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course.  PMID: 30873577
• Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge.  DOI: 10.1016/j.jped.2019.03.004
• Sa1942 – Real-World Implementation of the Low Fodmap Diet: Poor Compliance is Significantly Improved by Guidance from a Dietitian.  DOI: 10.1016/S0016-5085(19)38008-4
• Su1580 – A Longitudinal Study Examining the Effect of Altering Fodmap Intake on the Metabolome and Pain Signaling in IBS Patients.  DOI: 10.1016/S0016-5085(19)38319-2
• Mo1543 – The Effect of Low Fodmap Diet Management in Combination with Bifidobacteria on IBS Patients in Western China:A Prospective Randomized Trail.  DOI: 10.1016/S0016-5085(19)38887-0
• 860 – Low Fodmap Diet in the Long Term: Efficacy, Acceptability and Individual Perception of Trigger Foods. A Pilot Study.  DOI: 10.1016/S0016-5085(19)37269
• 347 – Is Sucrose the Sixth Fodmap in a Subset of Patients with Irritable Bowel Syndrome with Diarrhea and Sucrase Isomaltase Deficiency?.  DOI: 10.1016/S0016-5085(19)36959-8
• Mo1548 – Efficacy, Feasibility, and Safety of the Low Fodmap Diet for Children with Irritable Bowel Syndrome: A Prospective Cohort Study and Phone Survey.  DOI: 10.1016/S0016-5085(19)38892-4
• Sa1958 – Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times (FAST) Diary with Fodmap Analysis.  DOI: 10.1016/S0016-5085(19)38024
• Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.  PMID: 30945376
• Bacillus spp. Spores-A Promising Treatment Option for Patients with Irritable Bowel Syndrome.  PMID: 31438618
• Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?  PMID: 31327047
• Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition.  PMID: 31591348
• Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.  PMID: 31586453
• Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience.  PMID: 31571351
• Commentary: Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?  PMID: 31552257
• Low FODMAP diet significantly improves IBS symptoms: an Irish retrospective cohort study.  PMID: 31520160
• Gluten and FODMAPS-Sense of a Restriction/When Is Restriction Necessary?  PMID: 31434299
• Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones.  PMID: 31394793
• Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life.  PMID: 31336747
• Impaired cell surface expression and digestive function of sucrase-isomaltase gene variants are associated with reduced efficacy of low FODMAPs diet in patients with IBS-D.  PMID: 31331993
• Irritable bowel syndrome: how can symptoms and quality of life be improved with diet?  PMID: 31313689
• Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction.  PMID: 31309595
• Influence of Dietary Fiber in Low FODMAP Diet for Irritable Bowel Syndrome.  PMID: 31205130
• The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.  PMID: 31850930
• Technological Methods for Reducing the Content of Fructan in Wheat Bread.  PMID: 31835575
• All that a physician should know about FODMAPs.  PMID: 31802437
• Effect of Structural Individual Low-FODMAP Dietary Advice vs. Brief Advice on a Commonly Recommended Diet on IBS Symptoms and Intestinal Gas Production.  PMID: 31766497
• Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS).  PMID: 31727345
• Literature Review: Dietary Intervention Adherence and Adherence Barriers in Functional Gastrointestinal Disorder Studies.  PMID: 31714332
• The Pervasive Misunderstanding of What The FODMAP Diet Does And Does Not Do: Part 1.  Today’s Practitioner
• The Pervasive Misunderstanding of What the FODMAP Diet Does and Doesn’t Do: Part 2.  Today’s Practitioner 
• Impact of 24-hour high and low fermentable oligo- di- mono- saccharide polyol diets on markers of exercise-induced gastrointestinal syndrome in response to exertional-heat stress.  PMID: 31652404
• The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome. PMID: 31637777
• Observational Study on Knowledge and Eating Habits with Respect to Low- and High-FODMAP Foods in Medical Checkup Populations in Japan.  PMID: 31614902
• Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. PMID: 31421429
• The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.  PMID: 31290223
• Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge.  DOI: 10.1016/j.jped.2019.03.004